BACE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.365400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.012400E-01
Normal-vs-Stage2
6.400600E-01
Normal-vs-Stage3
8.358200E-01
Normal-vs-Stage4
9.467600E-01
Stage1-vs-Stage2
3.537600E-01
Stage1-vs-Stage3
8.959200E-01
Stage1-vs-Stage4
8.309400E-01
Stage2-vs-Stage3
3.163400E-01
Stage2-vs-Stage4
6.828000E-01
Stage3-vs-Stage4
7.694000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.617000E-01
Normal-vs-AfricanAmerican
9.299600E-01
Normal-vs-Asian
3.561200E-01
Caucasian-vs-AfricanAmerican
9.249000E-01
Caucasian-vs-Asian
1.776840E-01
AfricanAmerican-vs-Asian
3.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.832400E-01
Normal-vs-Female
9.972000E-01
Male-vs-Female
1.606010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.685400E-01
Normal-vs-Age(41-60Yrs)
9.453200E-01
Normal-vs-Age(61-80Yrs)
8.511000E-01
Normal-vs-Age(81-100Yrs)
1.502010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.626200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.086200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.608350E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.793000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.365500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.298420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.589400E-01
Normal-vs-Daily Drinker
2.149600E-01
Normal-vs-Weekly Drinker
9.696800E-01
Normal-vs-Occasional Drinker
9.956400E-01
Normal-vs-Social Drinker
9.951200E-01
Non Drinker-vs-Daily Drinker
2.264200E-01
Non Drinker-vs-Weekly Drinker
4.538200E-01
Non Drinker-vs-Occasional Drinker
5.613400E-01
Non Drinker-vs-Social Drinker
4.222600E-01
Daily Drinker-vs-Weekly Drinker
5.960300E-02
Daily Drinker-vs-Occasional Drinker
2.182200E-01
Daily Drinker-vs-Social Drinker
1.080440E-01
Weekly Drinker-vs-Occasional Drinker
9.515200E-01
Weekly Drinker-vs-Social Drinker
9.431400E-01
Occasional Drinker-vs-Social Drinker
9.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.812000E-01
Normal-vs-Grade 2
6.555600E-01
Normal-vs-Grade 3
6.714000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.986400E-02
Grade 1-vs-Grade 3
8.122200E-02
Grade 1-vs-Grade 4
7.812000E-01
Grade 2-vs-Grade 3
7.469600E-01
Grade 2-vs-Grade 4
6.555600E-01
Grade 3-vs-Grade 4
6.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.729200E-01
Normal-vs-NonDiabetic
7.553400E-01
Diabetic-vs-NonDiabetic
9.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.741000E-01
Normal-vs-NoPancreatitis
8.406000E-01
Pancreatitis-vs-NoPancreatitis
6.648500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.738600E-01
Normal-vs-N1
7.658200E-01
N0-vs-N1
8.473400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.412600E-01
Normal-vs-TP53-NonMutant
8.395600E-01
TP53-Mutant-vs-TP53-NonMutant
1.481460E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
